Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marissa L Cann

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Cellular Biochemistry|May 3, 2017
Measuring Kinase Activity-A Global ChallengeMarissa L Cann, Ian M McDonald, Michael P East, et al.
Journal of Proteome Research|December 13, 2018
Dasatinib Is Preferentially Active in the Activated B-Cell Subtype of Diffuse Large B-Cell LymphomaMarissa L Cann, Laura E Herring, Lauren L Haar, et al.
Targeted Oncology|August 21, 2019
Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing LymphomaSteven I Park, Carolina P Lin, Natalie Ren, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Cellular Biochemistry|May 3, 2017
Measuring Kinase Activity-A Global ChallengeMarissa L Cann, Ian M McDonald, Michael P East, et al.
Journal of Proteome Research|December 13, 2018
Dasatinib Is Preferentially Active in the Activated B-Cell Subtype of Diffuse Large B-Cell LymphomaMarissa L Cann, Laura E Herring, Lauren L Haar, et al.
Targeted Oncology|August 21, 2019
Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing LymphomaSteven I Park, Carolina P Lin, Natalie Ren, et al.
Pageof 1